Corcept Therapeutics Inc’s filing revealed that its Officer Guyer William acquired Company’s shares for reported $0.49 million on Nov 01 ’24. In the deal valued at $48.97 per share,10,000 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Guyer William sold 10,000 shares, generating $462,800 in total proceeds. Upon selling the shares at $46.28, the Chief Development Officer now owns 5,796 shares.
Before that, Robb Gary Charles sold 11,000 shares. Corcept Therapeutics Inc shares valued at $509,080 were divested by the Chief Business Officer at a price of $46.28 per share. As a result of the transaction, Robb Gary Charles now holds 22,772 shares, worth roughly $1.14 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Monday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 5.12% to $50.06. Over the last five days, the stock has gained 3.56%. Corcept Therapeutics Inc shares have risen nearly 54.13% since the year began. Nevertheless, the stocks have risen 97.94% over the past one year. While a 52-week high of $50.07 was reached on 11/04/24, a 52-week low of $20.84 was recorded on 04/22/24. SMA at 50 days reached $42.70, while 200 days put it at $31.48.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 48.02, which if violated will result in even more drops to 45.98. On the upside, there is a resistance level at 51.71. A further resistance level may holdings at 53.36. The Relative Strength Index (RSI) on the 14-day chart is 64.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.53%. Stochastics %K at 80.81% indicates the stock is a selling.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2024-10-15, dropping by -1.03 million shares to a total of 20.68 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 21.71 million shares. There was a decline of -4.98%, which implies that there is a negative sentiment for the stock.
